Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ilan Bikel is active.

Publication


Featured researches published by Ilan Bikel.


Cell | 1987

SV40 small t antigen enhances the transformation activity of limiting concentrations of SV40 large T antigen

Ilan Bikel; Ximena Montano; Mounzer E. Agha; Myles Brown; Melissa McCormack; Jay Boltax; David M. Livingston

A murine recombinant Neo(r) retrovirus encoding the SV40 small t antigen was used to infect Balb/c 3T3 CIA31 cells. From analyses of G418-resistant clones containing at least as much intact t as Cos-1 cells, we found that t, alone, had no detectable A31 transforming activity. In contrast, we noted that SV40 large T promoted A31 agar colony formation when present over a 5- to 7.5-fold concentration range. However, at the low end of the spectrum, its transforming effect was manifest inefficiently except in the presence of t. Thus a major role for t in the SV40 transforming mechanism is to enhance directly or indirectly the transforming function of T.


Cell | 1988

Trans-activation of RNA polymerase II and III promoters by SV40 small t antigen

Mary R. Loeken; Ilan Bikel; David M. Livingston; John N. Brady

A biochemical role for SV40 small t antigen (t) in the viral infectious cycle that would explain the strong conservation of t structure among papovaviruses and its role as a helper of SV40 large T antigen function in the viral transforming process is not understood. Here, we report an intracellular biochemical function of the protein--the capacity to trans-activate selected RNA polymerase II and III-requiring promoters. Since t has failed in the past to bind to DNA and did not stimulate all polymerase II-requiring promoters tested, it likely trans-activates, at least in part, by modifying the activity of selected transcription factors.


Cell | 1982

Role of small t antigen in the acute transforming activity of SV40

Harvey Rubin; James Figge; Mariluci T. Bladon; Lan Bo Chen; Ilan Bikel; Michael Farrell; David M. Livingston

A plasmid, pHR402, containing SV40 sequences that include a truncated early region bearing an intact t-coding sequence and a functionally intact late region, was introduced into thymidine kinase deficient (tk-) mouse L cells by cotransformation with a cloned tk gene. tk+ cotransformants synthesized SV40 t but not T antigen, and no truncated T-coding sequence products were detected. The viral sequences of pHR402 were reconstituted as a virus in COS1 cells, and acute infection of untransformed mouse cells with this viral stock (SV402) also led to the appearance of t but not T or a truncated T. Abortive transformation assays of such infected cells were negative, as were those performed on the same cells infected with either of two viral mutants (dl883 and dl884), each of which leads to T but not t synthesis. However, mixed infection with SV402 and either dl883 or dl884 led to a clear abortive and permanent transformation response. Thus, at least in part, t and T appear to function in a complementary fashion in eliciting transformation expression by SV40-infected cells.


Archives of Biochemistry and Biophysics | 1978

Purification and subunit structure of mouse liver cystathionase.

Ilan Bikel; Thales N. Pavlatos; David M. Livingston

Abstract Cystathionase has been purified from mouse liver by ammonium sulfate precipitation, ethanol precipitation, column chromatography on DEAE-cellulose and on hydrox-ylapatite, as well as Sephadex G-200 gel filtration. These procedures yielded a chromatographically homogeneous enzyme which was purified more than 1000-fold relative to whole liver extract. Overall recovery was approximately 4%. The purified enzyme does not contain detectable carbohydrate and migrates as a single protein component on analytical disc gel electrophoresis. A sedimentation coefficient of 8.3 S has been determined for the active enzyme by rate zonal centrifugation in glycerol gradients. This value suggests a molecular weight for the native enzyme of approximately 160,000 g/mol, a value similar to that estimated by gel filtration. Following sodium dodecyl sulfate gel electrophoresis in the presence of reducing agent and at different gel concentrations, a single protein component with a molecular weight of 40,000 g/mol was obtained. Thus, the enzyme appears to consist of four subunits of equal size. The Km value for cystathionine at pH 8.1, 37 °C, and in the presence of 1 m m dithioerythritol is approximately 1 m m .


Journal of Virology | 1986

A recombinant murine retrovirus for simian virus 40 large T cDNA transforms mouse fibroblasts to anchorage-independent growth.

Myles Brown; M McCormack; K G Zinn; M P Farrell; Ilan Bikel; David M. Livingston


Proceedings of the National Academy of Sciences of the United States of America | 1979

Synthesis of simian virus 40 t antigen in Escherichia coli.

Thomas M. Roberts; Ilan Bikel; R R Yocum; David M. Livingston; M Ptashne


Journal of Virology | 1988

Purification and functional properties of simian virus 40 large and small T antigens overproduced in insect cells.

C I Murphy; B Weiner; Ilan Bikel; Helen Piwnica-Worms; M K Bradley; David M. Livingston


Journal of Virology | 1994

Transrepression of RNA polymerase II promoters by the simian virus 40 small t antigen.

Won-Bo Wang; Ilan Bikel; Erika Marsilio; David Newsome; David M. Livingston


Proceedings of the National Academy of Sciences of the United States of America | 1990

Simian virus 40 small tumor antigen and an amino-terminal domain of large tumor antigen share a common transforming function.

X Montano; R Millikan; J M Milhaven; D A Newsom; John W. Ludlow; A K Arthur; E Fanning; Ilan Bikel; David M. Livingston


Molecular and Cellular Biology | 1986

The t-unique coding domain is important to the transformation maintenance function of the simian virus 40 small t antigen.

Ilan Bikel; Harvey J. Mamon; E L Brown; Jay Boltax; M Agha; David M. Livingston

Collaboration


Dive into the Ilan Bikel's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Helen Piwnica-Worms

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Jay Boltax

Beth Israel Deaconess Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge